Wajeeha Razaq is an Oncology physician affiliated with Oklahoma State University Oklahoma City. OpenAlex indexes 56 publications with 911 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
75.6%Aromatase Inhibitor49.6%Anastrozole65%Letrozole18%Exemestane17%Part D≥146 patientsKinase inhibitor23.1%Ibrance48%Verzenio23%Kisqali16%Everolimus10%Tukysa4%Part D<11 patients+ 2 more classes in this area
Nervous system
10.4%Gabapentinoids5%Gabapentin100%Part D≥19 patientsSNRI2.6%Venlafaxine Hcl Er100%Part D≥13 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.9%Serotonin-3 Receptor Antagonist4%Ondansetron Hcl100%Part D≥29 patientsPotassium supplement1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patterns of failure and outcomes in triple-negative compared to estrogen receptor–positive breast cancer.
Journal of Clinical Oncology
2026 - Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy.
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Courtney Houchen, MD
Oklahoma State University Oklahoma City
Jerry Jaboin, MD
Oklahoma State University Oklahoma City
Hassan Hatoum, MD
Oklahoma State University Oklahoma City
Manu Pandey, MD
Oklahoma State University Oklahoma City
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”